Deleted
Deleted Member
Posts: 0
|
Post by Deleted on May 25, 2016 15:24:17 GMT -5
Yea, the sky may be blue too Hi Matt We plan on selling some or all of the shares but more than likely we will choose to do neither. Actually I dont know why I even bothered to call you to tell you this if its so unlikely. reverselo, Just wondering if you are going to keep bitching as MNKD attempts to make a higher low, and the stop so close.? Pep
I dont think that is bitching. I think its reading a reality. I own the stock I am super happy its bouncing back especially since I have gone so heavy since the decline. Posters need to let people have an opinion outside of being absolutely in love with MNKD and every angle is bullish. Peppy you have quite the imagination and ramble on a lot but I never say anything to you. I let you have your opinion as you are entitled to it. I totally understand the way lefty is reading it but if it was a moot point it would never be disclosed. Thats the way I am interpretate the language. If this stock see's 2 bucks some time shortly I am prepared to react if someone is selling shares off VS being down 40% at the blink of an eye. |
|
|
|
Post by matt on May 25, 2016 15:32:17 GMT -5
There's nothing there that says they "plan" on selling. All it says is that they "may." Depending on circumstances I leave open the possibility that I also "may" sell, but the chances of my doing that anytime soon are highly unlikely. Trustees have a fiduciary obligation to act in the best interests of the beneficiaries of the trust. It doesn't matter what is best for Mannkind or what Al personally would have done or what Al's wishes would have been; all that matters is the language that made it into the trust indenture. Sometimes the drafting lawyer manages to accurately convey the grantor's wishes precisely and sometimes not, but it is difficult to get such things changed after death of the grantor.
A cardinal rule of trust law is that trustee must act with "prudence" and allocating an excessively large portion of the corpus of a trust to a single security is normally considered imprudent unless the grantor specifically provided otherwise. The trustees are usually lawyers and financial professionals that work for specialty divisions of banks or trust companies, and they take their responsibilities very seriously since they and their institutions can be sued for breaches of their fiduciary obligations by the beneficiaries if the value of the trust is diminished because the trustees failed to diversify the portfolio.
We can't know what is going to happen because we don't know what the grantor (Al) put in the trust documents, and because there are various trusts there may be different language in different grants. However, if the main contributions to the trusts were made with stock in entities that Al founded it would not be surprising to see a little portfolio realignment going forward. Time will tell.
|
|
|
|
Post by BlueCat on May 25, 2016 18:05:10 GMT -5
There's nothing there that says they "plan" on selling. All it says is that they "may." Depending on circumstances I leave open the possibility that I also "may" sell, but the chances of my doing that anytime soon are highly unlikely. Trustees have a fiduciary obligation to act in the best interests of the beneficiaries of the trust. It doesn't matter what is best for Mannkind or what Al personally would have done or what Al's wishes would have been; all that matters is the language that made it into the trust indenture. Sometimes the drafting lawyer manages to accurately convey the grantor's wishes precisely and sometimes not, but it is difficult to get such things changed after death of the grantor.
A cardinal rule of trust law is that trustee must act with "prudence" and allocating an excessively large portion of the corpus of a trust to a single security is normally considered imprudent unless the grantor specifically provided otherwise. The trustees are usually lawyers and financial professionals that work for specialty divisions of banks or trust companies, and they take their responsibilities very seriously since they and their institutions can be sued for breaches of their fiduciary obligations by the beneficiaries if the value of the trust is diminished because the trustees failed to diversify the portfolio.
We can't know what is going to happen because we don't know what the grantor (Al) put in the trust documents, and because there are various trusts there may be different language in different grants. However, if the main contributions to the trusts were made with stock in entities that Al founded it would not be surprising to see a little portfolio realignment going forward. Time will tell.
I think it is very fair to say we just don't know. It could be that formal notification to the companies that they have the right (from the trust) to sell any or all is just SOP, and not indicating any intent at all. Perhaps worth a check to see if the other companies like EYES or such received similar notifications. It would make some sense if Old Mann trusted the judgment and ethics now in control of those shares. Imagine (like an imaginary friend at moment) that some company made an offer and successfully acquired the company. They would have to be able to sell. Or if the company somehow merged or heavily partnered with another large company that had direct competing and conflicting interests with other companies within the Trust's portfolio. MNKD would be all set, but for the Trust - that would probably be the wrong type of diversification to maintain. I don't know the laws around this - but though I feel once again uneasy like the approach of a rocking chair - I just don't see anything conclusive here other than "its possible". |
|
|
|
PPS
May 31, 2016 5:21:53 GMT -5
Post by anderson on May 31, 2016 5:21:53 GMT -5
The foundation being greater than a 10% share holder is required to file 144 documents on any buy or sells. Are you sure it is a 10% share holder? I'm not sure where to find the official statement quickly, but the Al Mann foundation is not listed as a > 10% shareholder on Yahoo Finance or on the Mannkind site, so far as I can see. I suppose Mann's estate is probably still being settled, so maybe his shares have not been transferred over yet? Also, apparently his will stated that his shares would be split among several parties. The 10-Q below says his shares will be split among many parties, and does not say how much goes to each. Maybe his foundation never was / never will be a 10% owner? Filing Date: 11/9/2015 Form Type: 10-Q Page 43 At September 30, 2015, Alfred E. Mann, our Executive Chairman and principal stockholder, beneficially owned approximately 37.2% of our outstanding shares of capital stock. Upon his death, we have been advised by Mr. Mann that his shares of our capital stock will be left to the Alfred E. Mann Medical Research Organization (“AEMMRO”), and AEM Foundation for Biomedical Engineering (“AEMFBE”), not-for-profit medical research foundations that serve as funding organizations for Mr. Mann’s various charities, including the Alfred Mann Foundation (“AMF”), and the Alfred Mann Institutes at the University of Southern California, the Technion-Israel Institute of Technology, and Purdue University, and that may serve as funding organizations for any other charities that he may establish. The AEMMRO is a membership foundation consisting of nine members, including Mr. Mann, his wife, three of his children and Dr. Joseph Schulman, the chief scientist of the AEMFBE. The AEMFBE is a membership foundation consisting of five members, including Mr. Mann, his wife, and the same three of his children. Although we understand that the members of AEMMRO and AEMFBE have been advised of Mr. Mann’s objectives for these foundations, once Mr. Mann’s shares of our capital stock become the property of the foundations, we cannot assure you as to how those shares will be distributed or how they will be voted. Read more: mnkd.proboards.com/thread/5238/als-death-affect-mnkds-prospects#ixzz49e3rsyMK Note that Al Mann is not listed as a shareholder. Form DEF 14A Definitive Proxy Statement Filed Apr 21, 2016 on Page 35-36 SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT The following table sets forth certain information regarding the ownership of the Company’s common stock as of March 21, 2016 by: Beneficial Ownership Name and Address of Beneficial Owner Number of Shares Percent of Total Greater than 5% Stockholders The Mann Group LLC(1) 89,750,000 20.9 % Alfred E. Mann Living Trust(2) 156,875,213 36.6 % (1) The Alfred E. Mann Living Trust (the “Trust”) is the sole member and manager of The Mann Group LLC (“The Mann Group”). (2) Includes (i) the shares described in footnote (1) above, (ii) 41,068,142 shares held of record by the Trust, (iii) 6,432,006 shares held by Biomed Partners, LLC and Biomed Partners II, LLC, of which entities the Trust is a 0.1% managing member, (iv) 10,968 shares held by Mannco LLC, (v) 2,398,126 shares held by the AGC Trust, (vi) 10,634,611 shares held by the CGM Trust, and (vii) 3,651,442 shares which the Trust has the right to acquire within 60 days of March 21, 2015 pursuant to the exercise of outstanding options previously held by Alfred E. Mann prior to his passing. |
|
|
|
PPS
May 31, 2016 7:11:45 GMT -5
Post by airfrtman on May 31, 2016 7:11:45 GMT -5
 I have to chime in and say THIS IS A GREAT THREAD. Very informative !!!!
|
|
|
|
PPS
May 31, 2016 15:35:44 GMT -5
Post by trondisc on May 31, 2016 15:35:44 GMT -5
With us downtroddden Longs barely holding the $1 line, is it time to bail? I mean Afrezza is life-changing and future Technosphere iterations could change modern medicine however how long are you willing to suffer and wait? I for one am scared very sh*tless that MannKind cannot survive solo. I wish they would just sell the entire company for 10+ and call it a day. Until then, I know I'll never see my 30k back again. I cannot believe more Type 1 & Type 2's don't demand this product give the extreme rapid acting efficiency & discreet convenience?
|
|
|
|
Post by brotherm1 on May 31, 2016 16:46:48 GMT -5
With us downtroddden Longs barely holding the $1 line, is it time to bail? I mean Afrezza is life-changing and future Technosphere iterations could change modern medicine however how long are you willing to suffer and wait? I for one am scared very sh*tless that MannKind cannot survive solo. I wish they would just sell the entire company for 10+ and call it a day. Until then, I know I'll never see my 30k back again. I cannot believe more Type 1 & Type 2's don't demand this product give the extreme rapid acting efficiency & discreet convenience? I read through some of your posts. Health is more important than any money. You appear to be an emotional wreck. You should definitely sell, learn to let go, and hence open up room in your mind for positive things. |
|
|
|
Post by sportsrancho on May 31, 2016 17:54:36 GMT -5
With us downtroddden Longs barely holding the $1 line, is it time to bail? I mean Afrezza is life-changing and future Technosphere iterations could change modern medicine however how long are you willing to suffer and wait? I for one am scared very sh*tless that MannKind cannot survive solo. I wish they would just sell the entire company for 10+ and call it a day. Until then, I know I'll never see my 30k back again. I cannot believe more Type 1 & Type 2's don't demand this product give the extreme rapid acting efficiency & discreet convenience? 90% of people, or more, do not know about Afrezza. 50% of those people think it's off the market. I myself have never met a diabetic who knew about it. ( and I wear my Afrezza T-shirt all the time! ) The doctor I'm friends with would not buy MNKD stock because he said, why would I buy stock in a company whose partner isn't selling the drug? But....he's buying now:-))) ( It you want something done right do it yourself! I know it's scary, but the people on it can't imagine life with out it. Its more scary for them than anyone else. Let's give the M&M team time to get the ball rolling! GL |
|
|
|
Post by silentknight on Jun 1, 2016 10:05:58 GMT -5
With us downtroddden Longs barely holding the $1 line, is it time to bail? I mean Afrezza is life-changing and future Technosphere iterations could change modern medicine however how long are you willing to suffer and wait? I for one am scared very sh*tless that MannKind cannot survive solo. I wish they would just sell the entire company for 10+ and call it a day. Until then, I know I'll never see my 30k back again. I cannot believe more Type 1 & Type 2's don't demand this product give the extreme rapid acting efficiency & discreet convenience? I, and I'd wager many others on this board, are in for several multiples of your 30K investment and I'm not worried. Yes, I'd like to see a higher PPS than $1 more or less, and I'm deep into the red on my investment, but if you can't stomach the uncertainty associated with what might happen, then you should definitely sell and give yourself the peace of mind of not having to worry so much about where things go. MNKD might go under, or it might go gang-busters with the new marketing strategy and sell Afrezza by the truck loads. We don't know. Nobody does. When you invest in a company, especially one as speculative as MNKD is right now, it's risky. Without risk, there's usually no reward. MNKD will either make me rich or teach me a very, very expensive lesson. I'm hoping it's the former and I like their new strategy. Read Nate Pile's article with Forbes if you need a realistic breakdown of what the future looks like for the company. |
|
|
|
PPS
Jun 1, 2016 16:05:24 GMT -5
via mobile
steve likes this
Post by brotherm1 on Jun 1, 2016 16:05:24 GMT -5
With us downtroddden Longs barely holding the $1 line, is it time to bail? I mean Afrezza is life-changing and future Technosphere iterations could change modern medicine however how long are you willing to suffer and wait? I for one am scared very sh*tless that MannKind cannot survive solo. I wish they would just sell the entire company for 10+ and call it a day. Until then, I know I'll never see my 30k back again. I cannot believe more Type 1 & Type 2's don't demand this product give the extreme rapid acting efficiency & discreet convenience? Or perhaps you might be reading from a site such as the YMB where most of the posts are intended to create fear? I never go there for that reason. Don't know what your situation is, but don't neglect your health. A good life is well balanced. If you're losing in one area, balance it out in other areas with healthy things. jmo |
|
|
|
Post by patten1962 on Jun 2, 2016 6:50:13 GMT -5
With us downtroddden Longs barely holding the $1 line, is it time to bail? I mean Afrezza is life-changing and future Technosphere iterations could change modern medicine however how long are you willing to suffer and wait? I for one am scared very sh*tless that MannKind cannot survive solo. I wish they would just sell the entire company for 10+ and call it a day. Until then, I know I'll never see my 30k back again. I cannot believe more Type 1 & Type 2's don't demand this product give the extreme rapid acting efficiency & discreet convenience? 90% of people, or more, do not know about Afrezza. 50% of those people think it's off the market. I myself have never met a diabetic who knew about it. ( and I wear my Afrezza T-shirt all the time! ) The doctor I'm friends with would not buy MNKD stock because he said, why would I buy stock in a company whose partner isn't selling the drug? But....he's buying now:-))) ( It you want something done right do it yourself! I know it's scary, but the people on it can't imagine life with out it. Its more scary for them than anyone else. Let's give the M&M team time to get the ball rolling! GL I have said many times I work in healthcare. I have asked physicians about Afrezza, they have no idea. I have asked my diabetic patients, they have no idea. I have talked with a sanofi sales person,they said "we did nothing with afrezza". Imho, we must look at Mannkind as a start up company with zero sales. That fact we have any scripts is gravy. All of the diabetes on social media having great results is extra gravy! Let's not forget about a company like Vanguard who believes in us and keeps buying! Just my 2 cents! |
|
|
|
Post by trondisc on Jun 3, 2016 12:36:27 GMT -5
Anyone buying ((to go LONG that is only)) before the abstracts are released? Tempted but I can only spend $1000 vs. the $3000 I would like to spend.  Any other Longs purchasing shares today? Thoughts? Just feel like these abstracts are the first domino of game-changing positive news with a consistent ripple effect in education, exposure, sales. I wish nothing but the best for the company's tireless effort to help humanity as Al Mann had. |
|
Deleted
Deleted Member
Posts: 0
|
PPS
Jun 3, 2016 13:05:34 GMT -5
Post by Deleted on Jun 3, 2016 13:05:34 GMT -5
90% of people, or more, do not know about Afrezza. 50% of those people think it's off the market. I myself have never met a diabetic who knew about it. ( and I wear my Afrezza T-shirt all the time! ) The doctor I'm friends with would not buy MNKD stock because he said, why would I buy stock in a company whose partner isn't selling the drug? But....he's buying now:-))) ( It you want something done right do it yourself! I know it's scary, but the people on it can't imagine life with out it. Its more scary for them than anyone else. Let's give the M&M team time to get the ball rolling! GL I have said many times I work in healthcare. I have asked physicians about Afrezza, they have no idea. I have asked my diabetic patients, they have no idea. I have talked with a sanofi sales person,they said "we did nothing with afrezza". Imho, we must look at Mannkind as a start up company with zero sales. That fact we have any scripts is gravy. All of the diabetes on social media having great results is extra gravy! Let's not forget about a company like Vanguard who believes in us and keeps buying! Just my 2 cents! some if not all of that positions are many of MNKD retail share holders having retirement/brokerage accounts at fidelity/vanguard - and keep adding with the interest received by lending .. not fidelity/vanguard themselves... not sure about blackrock though |
|
|
|
PPS
Jun 3, 2016 13:55:54 GMT -5
via mobile
Post by sportsrancho on Jun 3, 2016 13:55:54 GMT -5
I have said many times I work in healthcare. I have asked physicians about Afrezza, they have no idea. I have asked my diabetic patients, they have no idea. I have talked with a sanofi sales person,they said "we did nothing with afrezza". Imho, we must look at Mannkind as a start up company with zero sales. That fact we have any scripts is gravy. All of the diabetes on social media having great results is extra gravy! Let's not forget about a company like Vanguard who believes in us and keeps buying! Just my 2 cents! some if not all of that positions are many of MNKD retail share holders having retirement/brokerage accounts at fidelity/vanguard - and keep adding with the interest received by lending .. not fidelity/vanguard themselves... not sure about blackrock though I thought this was the Vanguard Fund? People buy a mutual fund and they don't even know what stocks are in it. The fund it's self adds or decreases it's position. Please correct me if this isn't the case. |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Jun 3, 2016 15:00:43 GMT -5
I almost bought options yesterday for today. Decided not too. I got up this morning and saw worst job report since 2010and bought leveraged gold. Great trade for the day. Wish I invested more.
|
|
I have to chime in and say THIS IS A GREAT THREAD. Very informative !!!!
Any other Longs purchasing shares today? Thoughts? Just feel like these abstracts are the first domino of game-changing positive news with a consistent ripple effect in education, exposure, sales. I wish nothing but the best for the company's tireless effort to help humanity as Al Mann had.